Dr. Grace Tan graduated from Guy's King's and St Thomas's College of Medicine in London, UK.  She returned to complete her general surgery and surgical oncology training at Singapore General Hospital and the National Cancer Centre Singapore (NCCS). She then went on to complete her subspecialty training in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the NHS Peritoneal Malignancy Unit in Basingstoke, UK, and Pelvic Oncology Surgery in King Chulalongkorn Hospital in Bangkok, Thailand. The Basingstoke Peritoneal Malignancy Unit is a world-renowned institution for the treatment of peritoneal-based malignancies and has completed over 1200 CRS and HIPEC procedures. The King Chulalongkorn Hospital in Bangkok is one of the largest tertiary referral hospitals in Thailand and with internationally recognised expertise in the management of advanced pelvic cancers. ​

 

Dr. Tan is currently serving as an executive committee member for the Asian Peritoneal Surface Malignancy Group and as a member of the Gastrointestinal and Sarcoma Clinical Trial Steering Committee. She is also an examiner for both the Duke-NUS Graduate Medical School and NUS’ School of Medicine, and continues to be a speaker in the foundation course in clinical oncology at NCCS.

​

Dr. Tan has co-authored over 70 research papers that were published in journals such as Journal of Surgical Research and International Journal of Clinical Oncology, and is a reviewer for The Surgeon and the International Journal of Hyperthermia.

​

In recognition of her exceptional contributions, Dr. Tan was awarded the RISE awards for outstanding faculty in 2014, the 2017 Editor's Award for significant contribution by an investigator in the "Clinical" category, by the International Journal of Hyperthermia, and in 2019, she was awarded the Singapore Health Quality Service Gold Award.

 

Dr. Tan is experienced in the treatment of Gastrointestinal Cancers, Peritoneal and Pelvic malignancy, Melanoma and Sarcomas, and is passionate in providing the best holistic care for patients with cancer.